PHAGENESIS LIMITED

Active Manchester

Other research and experimental development on natural sciences and engineering

37 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
P

PHAGENESIS LIMITED

Other research and experimental development on natural sciences and engineering

Founded 10 Jul 2007 Active Manchester, England 37 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
Accounts Submitted 23 Sept 2025 Next due 30 Sept 2026 4 months remaining
Confirmation
Net assets £10M £35M 2024 year on year
Total assets £10M £9M 2024 year on year
Total Liabilities £764K £25M 2024 year on year
Charges 2
2 satisfied

Contact & Details

Contact

Registered Address

Unit 18 Enterprise House Pencroft Way, Manchester Science Park Manchester M15 6SE England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for PHAGENESIS LIMITED (06308699), an active life sciences and medical technology company based in Manchester, England. Incorporated 10 Jul 2007. Other research and experimental development on natural sciences and engineering. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type small
Next accounts 31 Dec 2025
Due by 30 Sept 2026 4 months remaining

Net Assets, Total Assets & Total Liabilities (2015–2024)

Cash in Bank

£9.38M

Increased by £8.88M (+1784%)

Net Assets

£9.70M

Increased by £34.70M (+139%)

Total Liabilities

£764.04k

Decreased by £25.40M (-97%)

Turnover

N/A

Employees

37

Increased by 11 (+42%)

Debt Ratio

7%

Decreased by 2253 (-100%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 4

Investors (7)

Investor NameInvestor SinceParticipating Rounds
Investor 7May 2013Series B
Investor 6Sept 2016Series C
Investor 1Mar 2024Series D

Share Capital

Share Capital

Share allotments and capital structure

8 Allotments 2,726,168 Shares £20.30m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
9 Dec 202598,727£987.27£0.01
19 Nov 20251,888£4k£1.99
6 Oct 202572,409£17k£0.23
6 Oct 202572,409£17k£0.23
1 Sept 202512,054£120.54£0.01

Officers

Officers

2 active 1 resigned
Status
Horace HoskinsDirectorAmericanUnited States4916 Aug 2024Active
Nichola ColeSecretaryUnknownUnknown15 May 2024Active

Shareholders

Shareholders (100)

Eqt Econimic 3 Cooperatief U.a
18.2%
765,292
Nutrition-wellness Venture S.a
12.7%
536,847

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Nestle S.a.

Switzerland

Active
Notified 31 May 2024
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Nestle S.a

Ceased 23 Feb 2024

Ceased

Group Structure

Group Structure

PHAGENESIS LIMITED Current Company

Charges

Charges

2 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
5 May 2026CapitalAllotment of shares (GBP 71,330.11) on 27 Apr 2026
5 May 2026OfficersAppointment of Mr Stephen Oesterle as director on 24 Apr 2026
2 Apr 2026OfficersChange to director Mr Fredrik Malte Tobias Edenius on 15 May 2024
11 Dec 2025CapitalAllotment of shares (GBP 58,215.36) on 9 Dec 2025
9 Dec 2025OfficersChange to director Mr Oern Stuge on 1 Aug 2025
5 May 2026 Capital

Allotment of shares (GBP 71,330.11) on 27 Apr 2026

5 May 2026 Officers

Appointment of Mr Stephen Oesterle as director on 24 Apr 2026

2 Apr 2026 Officers

Change to director Mr Fredrik Malte Tobias Edenius on 15 May 2024

11 Dec 2025 Capital

Allotment of shares (GBP 58,215.36) on 9 Dec 2025

9 Dec 2025 Officers

Change to director Mr Oern Stuge on 1 Aug 2025

Recent Activity

Latest Activity

Allotment of shares (GBP 71,330.11) on 27 Apr 2026

2 weeks ago on 5 May 2026

Appointment of Mr Stephen Oesterle as director on 24 Apr 2026

2 weeks ago on 5 May 2026

Change to director Mr Fredrik Malte Tobias Edenius on 15 May 2024

1 months ago on 2 Apr 2026

Allotment of shares (GBP 58,215.36) on 9 Dec 2025

5 months ago on 11 Dec 2025

Change to director Mr Oern Stuge on 1 Aug 2025

5 months ago on 9 Dec 2025